Pegylated PTH as PTH receptor modulators and uses thereof

Details for Australian Patent Application No. 2007313001 (hide)

Owner Eli Lilly and Company

Inventors Brown-Augsburger, Patricia Lea; Kohn, Wayne David

Agent Spruson & Ferguson

Pub. Number AU-B-2007313001

PCT Pub. Number WO2008/048784

Priority 60/829,383 13.10.06 US

Filing date 4 October 2007

Wipo publication date 24 April 2008

Acceptance publication date 22 March 2012

International Classifications

C07K 14/635 (2006.01) Peptides having more than 20 amino acids

A61K 38/29 (2006.01) Medicinal preparations containing peptides - Parathyroid hormone (parathormone)

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/048784 Priority application(s): WO2008/048784

22 March 2012 Application Accepted

  Published as AU-B-2007313001

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007313017-Phenylalkylamino carbamate compositions

2007312995-Bicyclic heteroaromatic compounds